| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,385,200 | 6,032,400 | 5,944,000 | 6,051,800 | | Cost of Revenue | 1,333,800 | 1,470,000 | 1,477,900 | 1,396,500 | | | Gross Profit | 4,051,400 | 4,562,400 | 4,466,100 | 4,655,300 | | | Operating Expenses | | Research Development | 1,224,200 | 1,386,600 | 1,171,100 | 1,169,300 | | Selling General and Administrative | 1,632,900 | 1,862,000 | 1,730,300 | 1,930,300 | | Non Recurring | 64,300 | 103,100 | 757,500 | 102,200 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,130,000 | 1,210,700 | 807,200 | 1,453,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 127,900 | (40,400) | 40,700 | 163,400 | | Earnings Before Interest And Taxes | 1,843,700 | 1,984,100 | 1,482,400 | 2,109,000 | | Interest Expense | 60,700 | 56,700 | 71,400 | 50,600 | | Income Before Tax | 1,783,000 | 1,927,400 | 1,411,000 | 2,058,400 | | Income Tax Expense | 327,200 | 282,600 | 318,200 | 290,200 | | Minority Interest |
-
| 93,900 | (31,100) | (30,900) | | | | Net Income From Continuing Ops | 1,455,800 | 1,644,800 | 1,092,800 | 1,768,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,455,800 | 1,644,800 | 1,092,800 | 1,768,200 | | Preferred Stock And Other Adjustments | (30,800) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,425,000 | $1,644,800 | $1,092,800 | $1,768,200 |
|
0.45% Nasdaq 
0.20%
Income Statement
